Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

CHICAGO — Patients who are new users of glucagon-like peptide-1 (GLP-1) receptor agonists have a low absolute risk of thyroid cancer, according to a new study presented at the American Thyroid ...

Differentiated thyroid carcinoma (DTC) is typically indolent, and some patients may be managed conservatively without immediate surgery. However, it remains a clinical challenge to determine who is ...

Please provide your email address to receive an email when new articles are posted on . Upcoming changes to thyroid nodule guidance could help further pinpoint cancer risk for patients. AI and ...

Popular diabetes and weight loss drugs like Ozempic and Wegovy, known as GLP-1 medications, were not found to cause a substantial increase in the risk of developing thyroid cancer, according to one of ...

There has been a tremendous rise in the rates of thyroid cancer at a faster rate than any other cancer across the world. The thyroid gland, present at the base of the neck - just below the Adam's ...

Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.

Thyroid cancer is a disease in which malignant (cancer) cells form in the tissues of the thyroid gland. In 2020, there were ...

Research isn’t clear on whether semaglutide causes thyroid tumors. But people with a history of thyroid cancer may want to avoid using this diabetes and weight loss medication. Semaglutide is in a ...

Share on Pinterest New research suggests that GLP-1 drugs like Ozempic and Wegovy are not likely to increase the risk of thyroid cancer. Jaap Arriens/NurPhoto via Getty Images There has been a concern ...